Hi-Tech Pharmacal’s ECR Subsidiary To Launch A New Dermatitis Treatment
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that it received clearance from the FDA to market Tropazone™ lotion, a prescription dermatological product which will be promoted by Hi-Tech’s branded marketing subsidiary, ECR Pharmaceuticals Co., Inc…